Brought to you by 
Inverness Medical Innovations buys Abbott's rapid Dx line
05 Nov 2003
Executive Summary
Concurrent with the settlement of disputes between the two companies, Inverness Medical Innovations (women's health diagnostics, vitamins, and nutritional supplements) has acquired several rapid diagnostic product lines and related IP from Abbott Laboratories for $92.6mm in cash and stock.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Inverness Medical Innovations buys Abbott's rapid Dx line
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice